Lung Neoplasms: all 7,334 studies
Page 14 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.
- PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung CancerRecruitingNCT05234307Phase 1
- A Study to Evaluate and Compare the Efficacy and Safety of XZP-3621 Versus CrizotinibNot yet recruitingNCT05204628Phase 3
- Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS BronchoscopyRecruitingNCT05203328Not applicable
- Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLCRecruitingNCT05203276Phase 2
- Lung Cancer Screening With Low-dose CT Scan in Women : Implementation StudyRecruitingNCT05195385Not applicable
- A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Positive Non-Small Cell Lung CancerNot yet recruitingNCT05186506Phase 2
- Targeted Telerehabilitation Following Curative Intent Therapy of Lung CancerRecruitingNCT05179408Not applicable
- Opioid Free Anaesthesia-Analgesia Strategy on Surgical Stress and Immunomodulation in Elective VATS-Lobectomy for NSCLCRecruitingNCT05172739Phase 4
- Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy SpecimensRecruitingNCT05171478
- Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung CancerRecruitingNCT05168566Phase 2
- The Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung CancerNot yet recruitingNCT05167851Phase 2
- Avera Cancer Sequencing and Analytics Protocol (ASAP)RecruitingNCT05142033
- Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung CancerRecruitingNCT05136846Phase 1
- Environment and Lung CancerRecruitingNCT05119244Not applicable
- A Study of Icotinib With Chemotherapy as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung CancerRecruitingNCT05104788Phase 2
- Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung CancerRecruitingNCT05098210Phase 1
- Anatomical Location and Metastasis Pattern of Intrapulmonary Lymph Nodes in NSCLC (ECTOP-1010)RecruitingNCT05094882
- The Cardiac Stress and Electrocardiographic Changes Caused by Lung Cancer SurgeryRecruitingNCT05094843
- A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)RecruitingNCT05085028Phase 3
- Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)RecruitingNCT05068232Phase 2
- A Study of FWD1509 in Adults With Non-Small Cell Lung CancerRecruitingNCT05068024Phase 1/2
- Application of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC PatientsNot yet recruitingNCT05066945
- Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung CancerRecruitingNCT05061550Phase 2
- Study of CXCR5 Modified EGFR Targeted CAR-T Cells for Advanced NSCLCRecruitingNCT05060796Early Phase 1
- Efficacy and Biomarker Development for Lung Cancer Treated With Immune Checkpoint InhibitorsRecruitingNCT05055908Phase 3
- Navigate - Improving Survival and Quality of Life in Vulnerable Lung Cancer PatientsRecruitingNCT05053997Not applicable
- Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical TrialRecruitingNCT05053802Phase 2
- PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target IdentificationRecruitingNCT05049837
- A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung CancerRecruitingNCT05042375Phase 3
- A Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain MetastasesRecruitingNCT05033691Not applicable
- Dose-painting Radiation for LA-NSCLCRecruitingNCT05031533Not applicable
- Respiratory Adaptive Computed Tomography: Feasibility Study on Real-Time Gated 4DCT for Lung Cancer RadiotherapyRecruitingNCT05030207Not applicable
- Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLCRecruitingNCT05011487Phase 2
- Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized ChemoradiationRecruitingNCT05010109Not applicable
- Sintilimab With Pemigatinib in Patients With PD-L1-positive and FGFR Mutated Advanced Non-small Cell Lung CancerRecruitingNCT05004974Phase 2
- Comparing Hypo-fractionated Intensity- Modulated Radiation Therapy to Standard- Fractionated IMRT Along With Chemotherapy and Immunotherapy for Non-Small Cell Lung CancerRecruitingNCT04992780Phase 2
- Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With SurgeryRecruitingNCT04991025Phase 2
- Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung CancerRecruitingNCT04977791
- MRD Monitoring in Lung Cancer After ResectionRecruitingNCT04976296
- Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung CancerRecruitingNCT04973293Not applicable
- Supplementation of n-3 PUFA in the Modulation of Lean Mass in Patients With Lung Cancer Receiving a High-protein DietRecruitingNCT04965129Not applicable
- Prolonged Air Leak (PAL) Autologous Blood Patch Intervention TrialEnrolling by invitationNCT04954625Not applicable
- Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung CancerRecruitingNCT04952480Phase 2
- JS-201 Combined With Lenvatinib in the Treatment of Small-cell Lung CancerRecruitingNCT04951947Phase 2
- A Phase III Study to Assess the Effects of Almonertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung CancerRecruitingNCT04951635Phase 3
- Comparison of Segmentectomy Versus Lobectomy for Non-small Cell Lung Cancer ≤ 2 cm in the Middle Third of the Lung FieldRecruitingNCT04944563Not applicable
- Clinico-biological Data Collection Study of Metastatic Lung CancerRecruitingNCT04944030Not applicable
- Non-risk Based Lang Cancer Screening With a One-off LDCTRecruitingNCT04938804Not applicable
- Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung CancerRecruitingNCT04919382Phase 2
- Improving Care for Rural Patients With Solid TumorsRecruitingNCT04916990Not applicable
- Observational Study of Afatinib 30 mg DailyRecruitingNCT04909073
- Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain MetastasesRecruitingNCT04899908Phase 2
- Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 TherapyRecruitingNCT04892953Phase 2
- Retrospective Observational Study on Prediction of Response to PD-1 Immunotherapy in Patients with NSCLCRecruitingNCT04886401
- Trial Exploring Combined Neoadjuvant Therapy With Pembrolizumab/Lenvatinib + Adjuvant Pembrolizumab in Pat. With NSCLCRecruitingNCT04875585Phase 2
- The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage IIIRecruitingNCT04871412Phase 3
- Routine Electronic Monitoring Of Quality Of Life -Poumon (REMOQOL-Poumon)RecruitingNCT04857970
- Chest Lymph Node Sampling in Patients With Advanced Lung Cancer to be Treated With Curative-intent Radiation TreatmentRecruitingNCT04852588Not applicable
- Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043)Not yet recruitingNCT04846634Phase 2
- Efficacy and Safety of PVT-1 Treatment in Patients With Advanced Non-Small Cell Lung CancerRecruitingNCT04840004Phase 2
- Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line ChemoradiotherapyRecruitingNCT04829708Phase 3
- A Prehabilitation Program to Boost Postoperative Functional Capacity in Surgical Lung Cancer PatientsRecruitingNCT04826835Not applicable
- A Window of Opportunity Study for Investigating Drug Tolerant Persister (DTP) to Neoadjuvant Osimertinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harbouring EGFR MutationsRecruitingNCT04816838Not applicable
- Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung CancerRecruitingNCT04814407
- LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNGRecruitingNCT04790682Not applicable
- Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung TrialRecruitingNCT04789681Phase 2
- Heterogeneity of Dendritic Cells in Colon and Non-small Cell Lung CancerRecruitingNCT04789252
- Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH StudyRecruitingNCT04783168Not applicable
- Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung CancerRecruitingNCT04780568Phase 1
- A Retrospective Study: Evaluation of the Efficacy of Immunotherapy With Rare Mutations in Non-small Cell Lung CancerRecruitingNCT04777175
- Adjuvant Toripalimab Plus Chemotherapy for EGFR/ALK Mutation Negative Stage II-IIIB(N2) NSCLC (LungMate-008)Not yet recruitingNCT04772287Phase 3
- Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid TumorsRecruitingNCT04771520Phase 2
- Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour ResectionEnrolling by invitationNCT04762459Phase 3
- MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung CancerRecruitingNCT04762199Phase 1
- Neoadjuvant Durvalumab/Anlotinib /Chemotherapy Plus Curative Resection in Stage III Non-Small-Cell Lung Cancer : A Single-arm Phase II StudyRecruitingNCT04762030Phase 2
- Almonertinib Plus Microwave Ablation in Advanced Non-small Cell Lung CancerNot yet recruitingNCT04755738Phase 2
- A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With ChemoradiotherapyRecruitingNCT04749394Phase 2
- Obstructive Sleep Apnea Influences Efficacy of PD-1-Based Immunotherapy Against Non-Small Cell Lung CancerRecruitingNCT04743752
- Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed.RecruitingNCT04737382Not applicable
- LALUCA Research Platform A Prospective Analysis of Lung Cancer Diagnosis and Management in Clinical PracticeRecruitingNCT04733430
- ENB-guided Ablation Therapy Combined With VATS in the Treatment of MPLCRecruitingNCT04730453
- Neoadjuvant Immunotherapy for Stage III Non-small Cell Lung CancerRecruitingNCT04728724Phase 2
- Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung CancerRecruitingNCT04726215Phase 2
- Monitoring Alectinib Treatment by Detection of ALK Translocations in Serial Blood Samples From Non-Small Cell Lung Cancer PatientsEnrolling by invitationNCT04708639
- Pan-Canadian Lung Cancer Observational Study (PALEOS)RecruitingNCT04706754
- TATE and Pembrolizumab (MK3475) in mCRC and NSCLCRecruitingNCT04701476Phase 2
- The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC.Enrolling by invitationNCT04691063Phase 3
- Comparison Between Endovascular and Bronchoscopic Tumor Marker Insertion for Real-time Stereotactic-guided Radiotherapy in Lung CancerRecruitingNCT04684186
- Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC PatientsRecruitingNCT04680377
- A Trial of RSC-1255 for Treatment of Patients With Advanced MalignanciesRecruitingNCT04678648Phase 1
- Molecular Signature From Tumor to Lymph NodesRecruitingNCT04677205
- Functional Lung Avoidance SPECT-guided Radiation Therapy of Lung CancerRecruitingNCT04676828Not applicable
- Narrow Band Imaging (NBI) Under Electronic Bronchoscope in Lung CancerNot yet recruitingNCT04676815
- 4D-MRI for Precision MedicineRecruitingNCT04657042
- The Rise in Robotic Atypical SegmentectomiesRecruitingNCT04644952
- Mediastinal Lymph Node Dissection Versus Spared Mediastinal Lymph Node Dissection in Stage I GGN NSCLCRecruitingNCT04631770Not applicable
- Genotyping of Ebus-tbna Supernant Cell-free Dna in NsclcRecruitingNCT04624373
- Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung CancerRecruitingNCT04614103Phase 2
- Educating Smokers About Lung Cancer Screening Using Tobacco QuitlinesRecruitingNCT04595422Not applicable
- Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive)RecruitingNCT04591002Phase 2